RK
Rajesh Kalra
About Rajesh Kalra
Data last updated:
Rajesh Kalra has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Surgitech Innovation Private Limited and Bioflex International Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The largest current company by reported revenue is Surgitech Innovation Private Limited at ₹23.37 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2018 | 2018 | ₹23.37 Cr (FY 2025) | Active | |
| Director | 20 Mar 2018 | 2018 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Kalra
Rajesh Kalra has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Surgitech Innovation Private Limited and Bioflex International Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The largest current company by reported revenue is Surgitech Innovation Private Limited at ₹23.37 Cr (FY 2025).
Rajesh Kalra is associated with 2 companies as Director, including Surgitech Innovation Private Limited (₹23.37 Cr), Bioflex International Private Limited.
Rajesh Kalra has expertise in Technology, General Business.
Rajesh Kalra has 8 years in corporate governance.
By reported revenue, the largest current company of Rajesh Kalra is Surgitech Innovation Private Limited, with revenue of ₹23.37 Cr (FY 2025).
Rajesh Kalra currently holds positions at 2 companies: Surgitech Innovation Private Limited (₹23.37 Cr), Bioflex International Private Limited.